DOI : 10.1055/s-00034925

Hämostaseologie

Ausgabe S 01 · Volume 41 · Juni 2021 DOI: 10.1055/s-011-51193


65th Annual Meeting of the Society of Thrombosis and Haemostasis Research
simply online, 22.-26.02.2021

Kongresspräsident: Prof. Lorenzo Alberio Lausanne, CH
Abstracts (HTML) Abstracts (PDF) Autorenliste
P07-01
Mancuso, ME; Olivieri, M; Santoro, C; Maro, G; Sommerer, P: A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
P07-02
Bonanad, S; Núñez, R; Poveda, JL; Kurnik, K; Goldmann, G; Andreozzi, V; Vandewalle, B; Santos, S: A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII
P07-03
Fischer, R; Eichler, H; Escuriola-Ettinghausen, C; Holstein, K; Hart, C; Kemkes-Matthes, B; Klamroth, R; Mondorf, W; Nimtz-Talaska, A; Richter, H; Severin, K; Wermes, C: Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
P07-04
Mancuso, ME; Olivieri, M; Santoro, C; Maro, G; Sommerer, P: A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
P07-05
Schön, K; Riedesel, J; Seyfert-Brandt, W; Mischnik, M; Pestel, S; Azar, W; Hardy, C; Nolte, MW; Claar, P: Characterization of rFIX fusion proteins enabling subcutaneous administration
P07-06
Mondorf, W; Eichler, H; Escuriola-Ettinghausen, C; Fischer, R; Holstein, K; Hart, C; Kemkes-Matthes, B; Klamroth, R; Krammer-Steiner, B; Nimtz-Talaska, A; Severin, K; Wermes, C; Richter, H: Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
P07-07
Fontana, G; Faleschini, M; Papa, N; Morel-Kopp, MC; Marconi, C; Giangregorio, T; Seri, M; Noris, P; Pecci, A; Savoia, A; Bottega, R: Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
P07-08
Mehic, D; Hofer, S; Haslacher, H; Ay, C; Pabinger, I; Gebhart, J: Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency
P07-09
Knoll Machado, S; Kraushaar, T; Röder, J; Claar, P; Hardy, C; Nolte, MW; Pestel, S; Bacher, M; Ponnuswamy, P: In vitro characterization of K5A and K5R variants of Factor IX
P07-10
Holstein, K; Eichler, H; Escuriola-Ettinghausen, C; Fischer, R; Hart, C; Kemkes-Matthes, B; Klamroth, R; Krammer-Steiner, B; Mondorf, W; Nimtz-Talaska, A; Richter, H; Severin, K; Wermes, C: Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
P07-11
Pabinger, I; Lissitchkov, T; Nagao, A; Lepatan, LM; Li, Y; Seifert, W; Mancuso, ME: Long-term efficacy and safety of rIX-FP prophylaxis in adult patients with haemophilia B on a 21-day dosing regimen
P07-12
Granzow, N; Gottstein, S; Klamroth, R: Monitoring pain and joint health in patients with haemophilia
P07-13
Bidlingmaier, C; Türknetz, M; Escuriola Ettingshausen, C; Kentouch, K; Olivieri, M; Eberl, W; Zieger, B; Kurnik, K; Königs, C: Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
P07-14
Oldenburg, J; Holzhauer, S; Wenning, S; Olivieri, M; Pfrepper, C: Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany
P07-15
Bertaggia Calderara, D; Zermatten, MG; Aliotta, A; Alberio, L: Usefulness of global assays to monitor treatment of a patient with Hemophilia A switching from factor to non-factor replacement therapy